The impact of chronic kidney disease on postoperative complications in patients undergoing revision total knee arthroplasty: A propensity matched analysis.

Chronic kidney disease Complications Mortality NSQIP Revision total knee arthroplasty Surgical outcomes

Journal

Journal of clinical orthopaedics and trauma
ISSN: 0976-5662
Titre abrégé: J Clin Orthop Trauma
Pays: India
ID NLM: 101559469

Informations de publication

Date de publication:
Historique:
received: 27 01 2019
revised: 01 06 2019
accepted: 03 06 2019
entrez: 1 2 2020
pubmed: 1 2 2020
medline: 1 2 2020
Statut: ppublish

Résumé

Though the role of chronic kidney disease (CKD) has been studied previously in primary arthroplasty procedures of the hips and knees, there is a paucity of literature analyzing CKD's impact on surgical outcomes in revision total knee arthroplasty (rTKA) patients. As the number of patients with CKD requiring revision surgery increases, more vigilant pre-operative and post-operative measures can be taken to ensure successful outcomes. This retrospective study sought to 1) determine differences in demographics and preoperative comorbidities of patients with normal or mild CKD and those with moderate/severe CKD and 2) establish moderate/severe CKD as an independent risk factor for complications in the 30-day postoperative period in patients undergoing rTKA. The ACS-NSQIP database was queried for patients who had undergone rTKA from 2005 to 2016. Patient were assigned to one of five CKD severity classes after eGFR calculation and were further stratified into two cohorts: stages 1/2 vs. stages 3/4/5. After propensity matching to generate a matched normal/mild CKD cohort of rTKA patients, univariate and multivariate analyses were used to assess differences and the impact of severe CKD on the risk for complications. There were significant differences in several demographic features, comorbidities, and complications between the two cohorts upon univariate analyses. Upon multivariate analyses, CKD of moderate/severe/failure status was found to be a significant independent risk factor for acute renal failure (OR 18.097, 95% CI 4.970-65.902, p < 0.001), blood transfusions (OR 1.697, 95% CI 1.500-1.919, p < 0.001), return to the operating room (OR 1.257, 95% CI 1.009-1.566, p = 0.041), extended length of stay (OR 1.707, 95% CI 1.292-2.255, p < 0.001), and mortality (OR 2.165, 95% CI 1.116-4.200, p = 0.022) in the 30-day postoperative period. This current study found moderate/severe CKD to be an independent risk factor for several complications and should guide healthcare professionals for better patient-optimization. Orthopaedic surgeons should factor in CKD severity in the management of patients undergoing rTKA to effectively mitigate the effects of adverse events.

Identifiants

pubmed: 32002004
doi: 10.1016/j.jcot.2019.06.002
pii: S0976-5662(19)30085-2
pmc: PMC6985015
doi:

Types de publication

Journal Article

Langues

eng

Pagination

147-153

Informations de copyright

© 2019 Delhi Orthopedic Association. All rights reserved.

Déclaration de conflit d'intérêts

None.

Références

N Engl J Med. 2004 Sep 23;351(13):1296-305
pubmed: 15385656
J Arthroplasty. 2014 Oct;29(10):2025-30
pubmed: 24973000
Am J Transplant. 2011 Sep;11(9):1785-91
pubmed: 21883910
Ann Intern Med. 1999 Mar 16;130(6):461-70
pubmed: 10075613
J Arthroplasty. 2014 Jun;29(6):1225-30
pubmed: 24556110
Arch Intern Med. 2004 Mar 22;164(6):659-63
pubmed: 15037495
Clin Geriatr Med. 2010 Aug;26(3):355-69
pubmed: 20699159
Spine (Phila Pa 1976). 2014 Jul 15;39(16):1311-2
pubmed: 24732861
Anesthesiol Clin. 2009 Dec;27(4):739-49
pubmed: 19942177
Caspian J Intern Med. 2011 Spring;2(2):205-12
pubmed: 24024017
J Arthroplasty. 2018 Jun;33(6):1926-1929
pubmed: 29402713
Blood Purif. 2017;43(1-3):179-188
pubmed: 28114143
BMC Nephrol. 2015 Dec 01;16:193
pubmed: 26620131
BMC Musculoskelet Disord. 2016 Apr 26;17:182
pubmed: 27113334
Lijec Vjesn. 2009 Jan-Feb;131(1-2):22-6
pubmed: 19348352
J Am Acad Orthop Surg. 2008 Jan;16(1):9-18
pubmed: 18180388
J Bone Joint Surg Am. 2015 Sep 2;97(17):1386-97
pubmed: 26333733
Orthopedics. 2014 Jul;37(7):e613-8
pubmed: 24992055
Clin Kidney J. 2017 Feb;10(1):1-8
pubmed: 28638599
J Arthroplasty. 2018 Sep;33(9):2956-2960
pubmed: 29871832
Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266
pubmed: 11904577
J Arthroplasty. 2015 Sep;30(9 Suppl):51-4
pubmed: 26122111
Curr Opin Anaesthesiol. 2016 Jun;29(3):413-20
pubmed: 26945308
Int J Urol. 2014 Dec;21(12):1245-52
pubmed: 25041641
Sci Rep. 2017 Jul 26;7(1):6504
pubmed: 28747700
Clin Pract (Lond). 2014;11(5):525-535
pubmed: 25589951
Transfus Med Hemother. 2013 Oct;40(5):302-9
pubmed: 24273483

Auteurs

Danny Lee (D)

George Washington University School of Medicine and Health Sciences, George Washington University, 2300 I Street NW, Washington, DC, 20037, USA.

Ryan Lee (R)

George Washington University School of Medicine and Health Sciences, George Washington University, 2300 I Street NW, Washington, DC, 20037, USA.

David Strum (D)

George Washington University School of Medicine and Health Sciences, George Washington University, 2300 I Street NW, Washington, DC, 20037, USA.

Jessica H Heyer (JH)

Department of Orthopaedic Surgery, The George Washington University, 900 23rd Street NW, Washington, DC, 20037, USA.

Taylor Swansen (T)

Department of Orthopaedic Surgery, The George Washington University, 900 23rd Street NW, Washington, DC, 20037, USA.

Rajeev Pandarinath (R)

Department of Orthopaedic Surgery, The George Washington University, 900 23rd Street NW, Washington, DC, 20037, USA.

Classifications MeSH